• PROMOTE YOUR VENTURE
    • Startup listings
    • IP & Tech listings
  • GET HELP
    • Search questions
    • Post projects
    • Search expert directory
  • RESOURCES
    • Document Center
    • Search for patents
    • Expert articles / posts
  • NEWS & EVENTS
    • Tech & IP News
  • My Account
  • Sign in
  • FOR PROFESSIONALS

Patents

68,025 found
SEE ALL IP TYPES
PATENTFIELD SEARCH
UPLOAD IP
Granted

Vascular graft

Vascular grafting is the use of transplanted or prosthetic blood vessels in surgical procedures. PTFE and Dacron are some of the most commonly used grafts. Grafts can be used for the aorta, femoral...

Granted

Cholesterol

Cholesterol, from the Ancient Greek chole- (bile) and stereos (solid) followed by the chemical suffix -ol for an alcohol, is an organic molecule. It is a sterol (or modified steroid),[3] a lipid mo...

Pending

Acute pulmonary cell injury

Acute pulmonary cell injury

Granted

Targeting mPGES-1

Targeting mPGES-1

Granted

Rapamycin-resistant T cells

Rapamycin-resistant T cells

Granted

Polymorphism detection in V...

Polymorphism detection in VMAT1

Granted

Antibody binding to cells

Antibody binding to cells

Granted

NC quantum dot memory devices

NC quantum dot memory devices

Granted

Labor biomarkers

Labor biomarkers

Granted

Intravascular fibrin clots

Intravascular fibrin clots

Granted

Hypoxia

Hypoxia (also known as Hypoxiation or Anoxemia) is a condition in which the body or a region of the body is deprived of adequate oxygen supply. Hypoxia may be classified as either generalized, affe...

Pending

RNA binding protein

RNA-binding proteins (often abbreviated as RBPs) are proteins that bind to the double or single stranded RNA[1] in cells and participate in forming ribonucleoprotein complexes. RBPs contain various...

Granted

Immunogenicity of antigens

Immunogenicity of antigens

Granted

Bcl-2 gene

Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inducing (pro-apoptot...

Granted

Immunogenicity of antigens

Immunogenicity of antigens

Granted

Magnetic resonance imaging

Magnetic resonance imaging (MRI), nuclear magnetic resonance imaging (NMRI), or magnetic resonance tomography (MRT) is a medical imaging technique used in radiology to investigate the anatomy and p...

Granted

Diseased articular cartilag...

Diseased articular cartilage treatment

Granted

Electronic/optoelectronic d...

Electronic/optoelectronic devices having nanoparticles

Granted

Antibody binding to cells

Antibody binding to cells

Granted

Cutaneous T cell lymphoma

Cutaneous T cell lymphoma (CTCL) is a class of non-Hodgkin's lymphoma, which is a type of cancer of the immune system. Unlike most non-Hodgkin's lymphomas (which are generally B-cell related), CTCL...

  • First
  • Prev
  • …
  • 2115
  • 2116
  • 2117
  • 2118
  • 2119
  • 2120
  • 2121
  • 2122
  • 2123
  • …
  • Next
  • Last
Your one-stop shop for innovation and intellectual property Join us today

About us

IP Nexus is an IP commercialisation company that builds successful startup companies by collaborating with inventors, universities and research institutes to identify high-potential inventions at an early stage and provide the commercial direction, fundraising expertise and management talent necessary to build outstanding companies. IP Nexus has particular focus and expertise in Asia.

Disclaimer

IP Nexus, including the Ask an Expert and Services Marketplace, is an interactive online service that makes it faster and easier for businesses to find and hire legal help solely based on their search preferences. We are not a law firm, do not provide any legal services, legal advice or lawyer referral services and do not provide or participate in any legal representation.

Content

  • PRICING
  • FREQUENTLY ASKED QUESTIONS
  • IP PROTECTION
  • IP TYPES
  • IP CLAIMS
  • OUR TEAM
  • STARTUPS
  • CONTACT US
  • BRAND ASSETS
  • TERM OF USE
  • PRIVACY POLICY
  • SEARCH PATENTS ON PATENTFIELD

Newsletter

Subscribe

Languages

© 2026 IP Nexus. All Rights Reserved.

Report content

      Contact form